﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Immunopathologia Persa</JournalTitle>
      <Issn>2423-8015</Issn>
      <Volume>9</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>06</Month>
        <DAY>17</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Galbanic acid of Ferula assa-foetida L, as a regulator of the AMPK pathway in reduction of lipid accumulation in HepG2 cells</ArticleTitle>
    <FirstPage>39479</FirstPage>
    <LastPage>39479</LastPage>
    <ELocationID EIdType="doi">10.34172/ipp.2023.39479</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hadis</FirstName>
        <LastName>Musavi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1860-2387</Identifier>
      </Author>
      <Author>
        <FirstName>Hajar</FirstName>
        <LastName>Shokri-Afra</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9558-7104</Identifier>
      </Author>
      <Author>
        <FirstName>Soleiman</FirstName>
        <LastName>Mahjoub</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9775-804X</Identifier>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Khonakdar-Tarsi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8630-1722</Identifier>
      </Author>
      <Author>
        <FirstName>Abouzar</FirstName>
        <LastName>Bagheri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-8040-5056</Identifier>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Memariani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-2052-4261</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ipp.2023.39479</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>11</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>01</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Hepatic fat accumulation is a complication of non-alcoholic fatty liver disease (NAFLD). An AMP-activated protein kinase (AMPK) reduces the synthesis of fatty acids by inhibiting sterol regulatory element-binding transcription factor 1-c (SREBP1-C) and acetyl COA carboxylase (ACC). Objectives: We aimed to investigate the impress of galbanic acid (Gal) from the Ferula plant on AMPK and its inhibitory effect on lipogenic enzymes in HepG2 cells. Materials and Methods: In an applied-fundamental study, HepG2 cells were treated for 24 hours with Gal in palmitate (Pal). Resveratrol (RSV) was conducted as a positive control. Fatty acid synthase (FAS) and SREBP1-C gene expression were evaluated by reverse transcription polymerase chain reaction (RT-PCR). FAS, phospho-acetyl-CoA carboxylase (P-ACC), P-AMPK, AMPK, SREBP-1c, and ACC protein levels were measured by western blotting. Lipid accumulation was investigated qualitatively and semi-quantitatively with oil red. Results: The semi-quantitative results of oil revealed a substantial reduction (P&lt;0.004) in lipid accumulation for treatment with Gal. The significant increase in the protein level of P-AMPK (P&lt;0.001) and P-ACC (P=0.054) and significant decrease in FAS (P&lt;0.003), SREBP-1c (P&lt;0.001) and ACC (P&lt;0.011) due to the effect galbanic acid was observed. FAS gene expression decreased significantly (P&lt;0.009), while the decrease in SREBP-1c gene expression was not significant (P=0.303). Conclusion: These findings direct that galbanic acid can be a new regulator of AMPK. Hence, the present study may introduce galbanic acid as a new plan to positively regulate the AMPK pathway, which leads to the regulation of various cellular processes.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Acetyl COA carboxylase</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">NAFLD</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">AMP-activated kinase</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Fatty acid synthase</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Galbanic acid</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Nonalcoholic fatty liver diseases</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>